Edaravone Intravenous Infusion 30mg/20mL (Edaravone I.V. Infusion “Nichiiko”® / エダラボン点滴静注液30mg「日医工」)

JPY ¥18,400

Japanese Cerebral Protective Agent (Free Radical Scavenger) (Edaravone 30mg/20mL). Intravenous infusion for improvement of neurological symptoms in acute-phase cerebral infarction. 20mL x 10 vials. Mfd. by Nichiiko Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥16,928
10 - 19 12% JPY ¥16,192
20 + 18% JPY ¥15,088
SKU: EDA-30-INJ Category:

Description

Product Overview / 商品概要

Edaravone Intravenous Infusion 30mg/20mL “Nichiiko” (エダラボン点滴静注液30mg「日医工」)
Generic: Edaravone / エダラボン
Therapeutic Category: Cerebral Protective Agent (Free Radical Scavenger) / 脳保護剤(フリーラジカルスカベンジャー)
Manufactured by: Nichiiko Co., Ltd. / 日医工株式会社

Composition & Specification / 組成・規格

Active Ingredient: Edaravone 30mg per 1 vial (20mL) / 1管(20mL)中 エダラボン 30mg
Additives: Sodium bisulfite 20mg, Citric acid hydrate, Sodium hydroxide, Tonicity agent, pH adjuster / 亜硫酸水素ナトリウム20mg、クエン酸水和物、水酸化ナトリウム、等張化剤、pH調節剤
Appearance: Aqueous injection; clear, colorless solution; pH 3.8–4.5; osmolality ratio approximately 1 (relative to normal saline)
外観: 水性注射剤、無色澄明の液、pH 3.8~4.5、浸透圧比 約1(生理食塩液に対する比)

Indications / 効能効果

EN: Improvement of neurological symptoms, activities of daily living disability, and functional impairment associated with acute-phase cerebral infarction
JA: 脳梗塞急性期に伴う神経症候、日常生活動作障害、機能障害の改善

Dosage and Administration / 用法用量

EN: Usually, one vial (30mg of edaravone) diluted with an appropriate volume of normal saline or equivalent is administered by intravenous infusion over 30 minutes, twice daily (morning and evening) in adults. Treatment should be initiated within 24 hours of onset and continued for no more than 14 days.
JA: 通常、成人に1回1管(エダラボンとして30mg)を適当量の生理食塩液等で用時希釈し、30分かけて1日朝夕2回の点滴静注を行う。発症後24時間以内に投与を開始し、投与期間は14日以内とする。

Contraindications / 禁忌

EN: 2.1 Patients with severe renal impairment; 2.2 Patients with a history of hypersensitivity to any component of this product
JA: 2.1 重篤な腎機能障害のある患者、2.2 本剤の成分に対し過敏症の既往歴のある患者

Regulatory Information / 規制情報

Approval No.: 22200AMX00982000
Sales Started: June 2011 / 2011年6月
Classification Code: 87119
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): 20mL x 10 vials [with oxygen scavenger and oxygen indicator] / 20mL×10管[脱酸素剤、酸素検知剤入り]
Other Available Packages (by special order): 20mL x 10 vials [with oxygen scavenger and oxygen indicator]

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Edaravone Intravenous Infusion 30mg/20mL (Edaravone I.V. Infusion “Nichiiko”® / エダラボン点滴静注液30mg「日医工」)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Edaravone Intravenous Infusion 30mg

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.